Advantages of long-term evaluation of doxorubicin-induced cardiotoxicity using human iPSC-derived cardiomyocyte sheet tissues with continuous contractile force measurement under constant pacing
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
With advancements in anticancer therapy, concerns over delayed cardiotoxicity are increasing, creating demand for precise in vitro systems to evaluate long-term cardiotoxic effects in drug discovery. In this study, we examined the impact of doxorubicin on the contractility of cell sheet tissues made from human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) maintained at a steady pacing rate of 1 Hz. Using our system for continuous contractile force measurement over 5 days, tissues exposed to 0.3 µM doxorubicin exhibited progressive force decline and arrhythmias, despite no significant changes in 4 biomarkers, ANP, BNP, NT-proBNP, and cTnT, sampled post-measurement. These findings suggest that indirect biomarker-based assessment of the cardiotoxicity of doxorubicin may be challenging. Notably, an increased slope during the relaxation stage preceded reduction in contraction amplitude in 0.3 µM-exposed tissues. Further analysis, dividing the relaxation into early, middle, and terminal phases, indicated that doxorubicin induces a rapid force decline during the early phase, followed by a gradual decrease in the terminal phase. We discussed the mechanistic basis of this toxicity based on intracellular Ca2+ dynamics. These insights derive from a system that enables stable, long-term measurement of contractile force under a consistent beating rate, and such technological advancements promise to enable more reliable evaluation of delayed cardiotoxicity in future drug development. Thus, our rate-controlled, continuous force platform reveals early relaxation-phase changes not detected by soluble biomarkers and offers a more sensitive in vitro approach for preclinical cardiotoxicity screening.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Advantages of long-term evaluation of doxorubicin-induced cardiotoxicity using human iPSC-derived cardiomyocyte sheet tissues with continuous contractile force measurement under constant pacing
- Date Crossref
- 05/12/2025
- Éditeur
- Oxford University Press (OUP)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.